Osteoporosis Center of Armenia Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2020
NCT04321837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Osteoporosis Center of Armenia

Active Ingredients

Drugs in Phase 2 Trials (3)

calcium (1 trial)

ibandronate (boniva) (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoporosis (Phase 2)

Osteoporosis, Postmenopausal (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3